Scan to Download
One power score. Smarter investment decisions
Taysha Gene Therapies Inc
TSHA2.990USD
+0.090+3.10%
Close 09/18, 16:00（ET）Quotes delayed by 15 min
2.862USD+2.862After-hours 09/19, 20:00 (ET)
815.46MMarket Cap
LossP/E TTM
Taysha Gene Therapies Inc
2.990
+0.090+3.10%
Quarterly
Quarterly+Annual
Quarterly
Annual
YOY
Hide blank rows
FY2025Q2
FY2025Q1
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021Q4
FY2021Q3
FY2021Q2
FY2021Q1
FY2020Q4
FY2020Q3
Total revenue
78.60%1.99M
-32.51%2.30M
-43.90%2.02M
-62.33%1.79M
-53.57%1.11M
-27.52%3.41M
44.04%3.60M
--4.75M
--2.40M
--4.71M
--2.50M
--0.00
--0.00
--0.00
----
----
----
----
----
----
Revenue
78.60%1.99M
-32.51%2.30M
-43.90%2.02M
-62.33%1.79M
-53.57%1.11M
-27.52%3.41M
44.04%3.60M
--4.75M
--2.40M
--4.71M
--2.50M
--0.00
--0.00
--0.00
----
----
----
----
----
----
Operating expenses
28.24%28.74M
-14.48%23.72M
13.16%21.95M
12.11%22.85M
-13.06%22.41M
30.45%27.74M
-8.49%19.40M
-19.94%20.38M
-22.75%25.78M
-57.17%21.27M
-57.36%21.20M
-49.77%25.46M
-18.15%33.37M
54.72%49.65M
170.72%49.72M
236.95%50.68M
--40.77M
--32.09M
--18.37M
--15.04M
R&D expenses
33.62%20.14M
-24.65%15.56M
20.84%15.32M
26.76%14.95M
-23.84%15.07M
65.07%20.66M
-8.51%12.68M
-29.71%11.79M
-15.80%19.79M
-67.23%12.51M
-63.44%13.86M
-57.56%16.77M
-23.29%23.51M
60.07%38.18M
209.28%37.92M
257.49%39.53M
--30.64M
--23.85M
--12.26M
--11.06M
Depreciation, depletion, and amortization
-6.83%300.00K
-7.69%300.00K
-24.00%304.00K
-9.37%300.00K
-19.50%322.00K
-1.81%325.00K
0.00%400.00K
10.33%331.00K
33.33%400.00K
10.33%331.00K
91.39%400.00K
80.72%300.00K
252.94%300.00K
837.50%300.00K
3383.33%209.00K
--166.00K
--85.00K
--32.00K
--6.00K
----
Operating profit
-25.61%-26.75M
11.96%-21.42M
-26.18%-19.93M
-34.71%-21.06M
8.92%-21.30M
-46.93%-24.33M
15.52%-15.80M
38.59%-15.63M
29.93%-23.38M
66.65%-16.56M
62.39%-18.70M
49.77%-25.46M
18.15%-33.37M
-54.72%-49.65M
-170.72%-49.72M
-236.95%-50.68M
---40.77M
---32.09M
---18.37M
---15.04M
Net non-operating interest income (expenses)
Non-operating interest income
29.10%1.86M
-21.68%1.33M
-11.50%1.70M
89.99%2.11M
545.74%1.44M
430.72%1.69M
865.33%1.92M
12222.22%1.11M
725.93%223.00K
2178.57%319.00K
586.21%199.00K
-75.68%9.00K
-32.50%27.00K
-78.79%14.00K
-40.82%29.00K
--37.00K
--40.00K
--66.00K
--49.00K
----
Non-operating interest expense
-37.04%17.00K
-34.48%19.00K
-96.91%22.00K
-98.37%24.00K
-98.13%27.00K
-97.89%29.00K
-10.43%713.00K
36.46%1.47M
93.81%1.44M
104.46%1.37M
15.20%796.00K
98.53%1.08M
282.99%743.00K
--672.00K
--691.00K
54200.00%543.00K
--194.00K
--0.00
--0.00
--1.00K
Special income (expenses)
-59.96%-1.73M
-2.73%-1.43M
-100.75%-465.00K
93.60%-6.47M
---1.08M
---1.39M
271.21%62.35M
---101.07M
----
----
---36.42M
--0.00
----
----
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Other non-operating income (expenses)
-664.29%-237.00K
360.00%13.00K
-186.96%-66.00K
-326.32%-81.00K
1300.00%42.00K
37.50%-5.00K
-283.33%-23.00K
-1800.00%-19.00K
200.00%3.00K
0.00%-8.00K
---6.00K
---1.00K
---3.00K
---8.00K
----
----
----
----
----
----
Income before tax
-28.45%-26.88M
10.52%-21.53M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
185.68%47.74M
-341.39%-117.09M
27.85%-24.60M
64.98%-17.62M
-10.59%-55.72M
48.18%-26.53M
16.70%-34.09M
-57.12%-50.32M
-175.06%-50.39M
-240.29%-51.19M
---40.93M
---32.02M
---18.32M
---15.04M
Income tax
----
--0.00
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
----
Income after tax
-28.45%-26.88M
10.52%-21.53M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
185.68%47.74M
-341.39%-117.09M
27.85%-24.60M
64.98%-17.62M
-10.59%-55.72M
48.18%-26.53M
16.70%-34.09M
-57.12%-50.32M
-175.06%-50.39M
-240.29%-51.19M
---40.93M
---32.02M
---18.32M
---15.04M
Net income from continuous operations
-28.45%-26.88M
10.52%-21.53M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
185.68%47.74M
-341.39%-117.09M
27.85%-24.60M
64.98%-17.62M
-10.59%-55.72M
48.18%-26.53M
16.70%-34.09M
-57.12%-50.32M
-175.06%-50.39M
-240.29%-51.19M
---40.93M
---32.02M
---18.32M
---15.04M
Net income attributable to controlling interests
-28.45%-26.88M
10.52%-21.53M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
185.68%47.74M
-341.39%-117.09M
27.85%-24.60M
64.98%-17.62M
-10.59%-55.72M
48.18%-26.53M
16.70%-34.09M
-57.12%-50.32M
-175.06%-50.39M
-240.29%-51.19M
---40.93M
---32.02M
---18.32M
---15.04M
Net income attributable to common shareholders
-28.45%-26.88M
10.52%-21.53M
-139.35%-18.79M
78.20%-25.52M
14.92%-20.93M
-36.54%-24.06M
185.68%47.74M
-341.39%-117.09M
27.85%-24.60M
64.98%-17.62M
-10.59%-55.72M
48.18%-26.53M
16.70%-34.09M
-57.12%-50.32M
-175.06%-50.39M
-240.29%-51.19M
---40.93M
---32.02M
---18.32M
---15.04M
Basic earnings per share
-0.36%-0.09
23.17%-0.08
-130.87%-0.07
89.77%-0.10
76.52%-0.09
62.65%-0.10
123.00%0.23
-43.75%-0.93
54.92%-0.38
78.87%-0.28
25.42%-0.99
51.89%-0.65
22.22%-0.85
-52.26%-1.32
-149.12%-1.32
-209.11%-1.35
---1.09
---0.87
---0.53
---0.44
Diluted earnings per share
-0.36%-0.09
23.17%-0.08
-130.87%-0.07
89.77%-0.10
76.52%-0.09
62.65%-0.10
123.00%0.23
-43.75%-0.93
54.92%-0.38
78.87%-0.28
25.42%-0.99
51.89%-0.65
22.22%-0.85
-52.26%-1.32
-149.12%-1.32
-209.11%-1.35
---1.09
---0.87
---0.53
---0.44
Dividend per share
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
--0.00
Currency unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit opinions
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
--
